PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
Yield10 Bioscience, Inc. (YTEN)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN

US98585K8624

CUSIP

98585K862

Sector

Basic Materials

IPO Date

Nov 10, 2006

Highlights

Market Cap

$345.46K

EPS (TTM)

-$20.14

Total Revenue (TTM)

$750.00K

Gross Profit (TTM)

$750.00K

EBITDA (TTM)

-$5.52M

Year Range

$0.00 - $10.74

Target Price

$2.50

Short %

0.45%

Short Ratio

0.03

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Yield10 Bioscience, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%20.00%SeptemberOctoberNovemberDecember2025February
-100.00%
10.29%
YTEN (Yield10 Bioscience, Inc.)
Benchmark (^GSPC)

Returns By Period

Yield10 Bioscience, Inc. had a return of -95.19% year-to-date (YTD) and -99.78% in the last 12 months. Over the past 10 years, Yield10 Bioscience, Inc. had an annualized return of -76.37%, while the S&P 500 had an annualized return of 11.26%, indicating that Yield10 Bioscience, Inc. did not perform as well as the benchmark.


YTEN

YTD

-95.19%

1M

1,400.00%

6M

-98.81%

1Y

-99.78%

5Y*

-84.79%

10Y*

-76.37%

^GSPC (Benchmark)

YTD

4.01%

1M

1.13%

6M

9.82%

1Y

22.80%

5Y*

12.93%

10Y*

11.26%

*Annualized

Monthly Returns

The table below presents the monthly returns of YTEN, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2025-99.36%-95.19%
2024-1.92%0.77%60.68%-37.92%-66.26%-37.17%52.50%-30.05%-17.97%-46.67%-7.14%-40.00%-94.57%
2023133.60%-24.87%-5.80%3.26%-1.75%-20.71%-6.31%-82.84%-8.49%-0.52%-16.92%-11.37%-85.67%
2022-25.81%15.07%26.19%-42.26%-13.40%-15.09%7.11%30.29%-4.78%0.00%-21.07%-29.26%-66.07%
2021157.44%-2.96%-13.16%-26.24%-10.92%3.52%-16.76%-4.37%-11.78%-0.33%-17.09%-0.61%-14.88%
2020-7.14%3.45%-42.79%58.09%0.67%4.33%-1.28%-17.80%52.95%-29.34%26.96%-17.07%-15.74%
201920.48%25.00%-8.80%-4.39%-26.61%21.10%-14.83%-4.31%-36.42%-28.41%-65.19%37.09%-79.34%
20181.69%-15.55%28.28%-8.72%-4.49%-17.06%-12.77%30.08%-10.00%-2.08%-9.93%-34.65%-53.11%
20177.66%-4.91%2.71%62.26%-15.26%1.78%-41.75%-10.33%18.59%-11.60%-18.44%-23.04%-49.43%
2016-44.02%76.31%25.00%-20.00%-47.37%3.75%-28.34%-28.04%5.14%11.11%-42.02%20.73%-77.27%
20154.47%51.16%-4.62%24.19%-5.19%-14.38%-7.20%-40.22%-33.66%85.51%-19.14%-25.60%-37.64%
201413.49%-10.49%1.56%-20.77%-20.35%6.05%-42.53%38.00%31.88%-25.13%-19.27%-25.16%-67.33%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of YTEN is 47, indicating average performance compared to other stocks on our website. Here’s a breakdown of how it compares using common performance measures.


The Risk-Adjusted Performance Rank of YTEN is 4747
Overall Rank
The Sharpe Ratio Rank of YTEN is 3939
Sharpe Ratio Rank
The Sortino Ratio Rank of YTEN is 9090
Sortino Ratio Rank
The Omega Ratio Rank of YTEN is 9191
Omega Ratio Rank
The Calmar Ratio Rank of YTEN is 00
Calmar Ratio Rank
The Martin Ratio Rank of YTEN is 1414
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Yield10 Bioscience, Inc. (YTEN) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


Sharpe ratio
The chart of Sharpe ratio for YTEN, currently valued at -0.14, compared to the broader market-2.000.002.00-0.141.74
The chart of Sortino ratio for YTEN, currently valued at 2.86, compared to the broader market-4.00-2.000.002.004.006.002.862.36
The chart of Omega ratio for YTEN, currently valued at 1.42, compared to the broader market0.501.001.502.001.421.32
The chart of Calmar ratio for YTEN, currently valued at -1.00, compared to the broader market0.002.004.006.00-1.002.62
The chart of Martin ratio for YTEN, currently valued at -1.23, compared to the broader market-10.000.0010.0020.0030.00-1.2310.69
YTEN
^GSPC

The current Yield10 Bioscience, Inc. Sharpe ratio is -0.14. This value is calculated based on the past 1 year of trading data and takes into account price changes and dividends.

Use the chart below to compare the Sharpe ratio of Yield10 Bioscience, Inc. with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.


Rolling 12-month Sharpe Ratio0.001.002.003.00SeptemberOctoberNovemberDecember2025February
-0.14
1.74
YTEN (Yield10 Bioscience, Inc.)
Benchmark (^GSPC)

Dividends

Dividend History


Yield10 Bioscience, Inc. doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%SeptemberOctoberNovemberDecember2025February
-100.00%
0
YTEN (Yield10 Bioscience, Inc.)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Yield10 Bioscience, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Yield10 Bioscience, Inc. was 100.00%, occurring on Jan 16, 2025. The portfolio has not yet recovered.

The current Yield10 Bioscience, Inc. drawdown is 100.00%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-100%Feb 22, 20084254Jan 16, 2025
-10.43%Jan 16, 20078Jan 25, 200713Feb 13, 200721
-7.21%Mar 14, 20072Mar 15, 200718Apr 11, 200720
-5.48%Mar 2, 20072Mar 5, 20071Mar 6, 20073
-4.96%Nov 17, 20063Nov 21, 200611Dec 7, 200614

Volatility

Volatility Chart

The current Yield10 Bioscience, Inc. volatility is 209.78%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%100.00%200.00%300.00%400.00%500.00%SeptemberOctoberNovemberDecember2025February
209.78%
3.07%
YTEN (Yield10 Bioscience, Inc.)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Yield10 Bioscience, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Historical P/E Ratio Chart

The chart below displays the historical trend of the price-to-earnings (P/E) ratio for Yield10 Bioscience, Inc..


Loading data...

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab